Evidence map›Paper›PMID 27852286›Full record

Trial reportTrials2016

The Carotid and Middle cerebral artery Occlusion Surgery Study (CMOSS): a study protocol for a randomised controlled trial.

Yan Ma, Yuxiang Gu, Xiaoguang Tong, Jiyue Wang, Dong Kuai, Donghai Wang, Jun Ren, Lian Duan, Aili Maimaiti, Yiling Cai and 7 more

Registry-linked trialOpen access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Trials, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01758614 (The Carotid and Middle Cerebral Artery Occlusion Surgery Study), which is not on this map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01758614 phase3completednot on this map

The Carotid and Middle Cerebral Artery Occlusion Surgery Study

TypeinterventionalSponsorXuanwu Hospital, BeijingRan2013 to 2020Enrolled330ConditionsCarotid Artery Occlusion, Middle Cerebral Artery Occlusion, StrokeArmsbypass surgery, Aspirin, Clopidogrel
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. A critical appraisal of bypass surgery in moyamoya disease.Therapeutic advances in neurological disorders · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 13 institutions in 1 country.

Yan MaDepartment of Neurosurgery, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Beijing, China.
Yuxiang GuDepartment of Neurosurgery, Huashan Hospital, Fu Dan University, No. 12 Mid Wulumuqi Road, Shanghai, 200040, China.
Xiaoguang TongDepartment of Neurosurgery, Huanhu Hospital, No. 6 Jizhao Road, Tianjin, 300350, China.
Jiyue WangDepartment of Neurosurgery, Brain Hospital, No. 45 Huashan Road, LiaoCheng, Shandong, 252000, China.
Dong KuaiDepartment of Neurosurgery, The 1st Affiliated Hospital of ShanXi Medical University, No. 85 South Jiefang Road, Taiyuan, Shanxi, 030001, China.
Donghai WangDepartment of Neurosurgery, Qilu Hospital of Shandong University, No. 107 West Wenhua Road, Jinan, Shandong, 250012, China.
Jun RenDepartment of Neurosurgery, The 2nd Affiliated Hospital of LanZhou University, No. 80 Cuiyingmen Road, Lanzhou, Gansu, 730030, China.
Lian DuanDepartment of Neurosurgery, The 307 Hospital of PLA, No. 8 Dongda Street, Beijing, 100071, China.
Aili MaimaitiDepartment of Neurosurgery, The 1st Affiliated Hospital of XinJiang Medical University, No. 137 South Liyushan Road, Wulumuqi, Xinjiang Uyghur Autonomous Region, 830054, China.
Yiling CaiDepartment of Neurology, The 306 Hospital of PLA, No. 9 Anxiangbeili, Beijing, 100101, China.
Yujie HuangDepartment of Neurosurgery, Drum Tower Hospital, Medical School of Nanjing University, No. 321 Zhongshan Road, Nanjing, Jiangsu, 210008, China.
Xiaojian WangDepartment of Neurosurgery, The 1st Affiliated Hospital of Anhui Medical University, No. 218 Jixi Road, Hefei, Anhui, 650101, China.
Yi CaoDepartment of Neurosurgery, The 2nd Affiliated Hospital of Kunming Medical University, No. 324 Dianmian Road, Kunming, Yunnan, 610041, China.
Chao YouDepartment of Neurosurgery, West China Hospital of Sichuan University, No. 37 Guoxue Street, Chengdu, Sichuan, 610041, China.
Jiasheng YuDepartment of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095 Jiefang Road, Wuhan, Hubei, 430030, China.
Liqun JiaoDepartment of Neurosurgery, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Beijing, China. jiaoliqun@sina.cn.
Feng LingDepartment of Neurosurgery, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Beijing, China.
Capital Medical University · CN307th Hospital of Chinese People’s Liberation Army · CNFirst Affiliated Hospital of Anhui Medical University · CNHuashan Hospital · CNKunming Medical University · CNNanjing Drum Tower Hospital · CNPLA 306 Hospital · CNQilu Hospital of Shandong University · CNShanxi Medical University · CNTianjin Huanhu Hospital · CNTongji Hospital · CNWest China Hospital of Sichuan University · CNXinjiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with symptomatic internal carotid artery (ICA) or middle cerebral artery (MCA) occlusion with haemodynamic insufficiency are at high risk for recurrent stroke when treated medically.

methodsThe Carotid or Middle cerebral artery Occlusion Surgery Study (CMOSS) trial is an ongoing, government-funded, prospective, multicentre, randomised controlled trial. The CMOSS will recruit 330 patients with symptomatic ICA or MCA occlusion (parallel design, 1:1 allocation ratio) and haemodynamic insufficiency. Participants will be allocated to best medical treatment alone or best medicine plus extracranial-intracranial (EC-IC) bypass surgery. The primary outcome events are all strokes or deaths occurring between randomisation and 30 days post operation or post randomisation and ipsilateral ischaemic stroke within 2 years. Recruitment will be finished by December 2016. All the patients will be followed for at least 2 years. The trial is scheduled to complete in 2019. DISCUSSION: The CMOSS will test the hypothesis that EC-IC bypass surgery plus best medical therapy reduces subsequent ipsilateral ischaemic stroke in patients with symptomatic ICA or MCA occlusion and haemodynamic cerebral ischaemia. This manuscript outlines the rationale and the design of the study. CMOSS will allow for more critical reappraisal of the EC-IC bypass for selected patients in China.

trial registrationNCT01758614 with ClinicalTrials.gov. Registered on 24 December 2012.

Indexed as

Carotid Artery, InternalRisk Reduction BehaviorAdolescentAdultAgedCardiovascular AgentsCarotid StenosisCerebral RevascularizationCerebrovascular CirculationChinaClinical ProtocolsCollateral CirculationCombined Modality TherapyFemaleHemodynamicsHumansCardiovascular AgentsBypass surgeryCarotid arteryChinaHaemodynamicIschaemic strokeMiddle cerebral arteryOcclusion

Identifiers

PMID27852286
PMCPMC5111211
OpenAlexW2549311485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.